The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy
- PMID: 15280088
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy
Abstract
A single amino acid substitution in hemoglobin comprises the molecular basis for sickle cell anemia, but evolution of the corresponding clinical disease is extraordinarily complicated and likely involves multiple pathogenic factors. Sickle disease is fundamentally an inflammatory state, with activation of the endothelium, probably through proximate effects of reperfusion injury physiology and chronic molestation by adherent red cells and white cells. The disease also involves enhanced angiogenic propensity, activation of coagulation, disordered vasoregulation, and a component of chronic vasculopathy. Sickle cell anemia is truly an endothelial disease, and it is likely that genetic differences in endothelial function help govern its astonishing phenotypic diversity.
Similar articles
-
Special issue of Microcirculation: examination of the vascular pathobiology of sickle cell anemia. Foreword.Microcirculation. 2004 Mar;11(2):99-100. Microcirculation. 2004. PMID: 15280085 No abstract available.
-
Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain.Hematol Oncol Clin North Am. 2014 Apr;28(2):181-98. doi: 10.1016/j.hoc.2013.11.005. Hematol Oncol Clin North Am. 2014. PMID: 24589261 Review.
-
Sickle red cell microrheology and sickle blood rheology.Microcirculation. 2004 Mar;11(2):209-25. doi: 10.1080/10739680490279410. Microcirculation. 2004. PMID: 15280093 Review.
-
Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.Hemoglobin. 2009;33(1):1-16. doi: 10.1080/03630260802625709. Hemoglobin. 2009. PMID: 19205968 Review.
-
Sickle cell disease at the dawn of the molecular era.Hemoglobin. 2009;33 Suppl 1:S93-S106. doi: 10.3109/03630260903347617. Hemoglobin. 2009. PMID: 20001639 Review.
Cited by
-
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H328-36. doi: 10.1152/ajpheart.00500.2012. Epub 2012 Nov 2. Am J Physiol Heart Circ Physiol. 2013. PMID: 23125208 Free PMC article.
-
Adenosine signaling in normal and sickle erythrocytes and beyond.Microbes Infect. 2012 Aug;14(10):863-73. doi: 10.1016/j.micinf.2012.05.005. Epub 2012 May 23. Microbes Infect. 2012. PMID: 22634345 Free PMC article. Review.
-
Spatiotemporal dysfunction of the vascular permeability barrier in transgenic mice with sickle cell disease.Anemia. 2012;2012:582018. doi: 10.1155/2012/582018. Epub 2012 Jun 12. Anemia. 2012. PMID: 22778926 Free PMC article.
-
Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.J R Soc Med. 2016 Aug;109(8):303-9. doi: 10.1177/0141076816651037. Epub 2016 Jun 20. J R Soc Med. 2016. PMID: 27325377 Free PMC article.
-
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.Blood. 2010 Mar 25;115(12):2483-90. doi: 10.1182/blood-2009-02-204990. Epub 2010 Jan 6. Blood. 2010. PMID: 20053759 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical